Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-07T20:20:27.426Z Has data issue: false hasContentIssue false

Chapter 6 - Movement disorders in systemic infections

from Section II - Movement disorders in systemic disease

Published online by Cambridge University Press:  05 April 2014

Francisco Cardoso
Affiliation:
Movement Disorders Unit, Neurology Division, Internal Medicine Department, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
Werner Poewe
Affiliation:
Medical University Innsbruck
Joseph Jankovic
Affiliation:
Baylor College of Medicine, Texas
Get access

Summary

Introduction

The aim of this chapter is to describe movement disorders associated with infections that do not involve invasion of the central nervous system (CNS) by the etiologic agent. The prototype of condition where a systemic infection causes a movement disorder is rheumatic fever (RF). Already in the seventeenth century in England, Thomas Sydenham provided a detailed clinical description which would be named after him. However, its causal relationship with streptococcal infection was only firmly established in the middle of the twentieth century (Taranta and Stollerman 1956). The incidence of Sydenham’s chorea (SC) has markedly decreased in North America and Western Europe since 1960. Nevertheless, it remains the most common of acute choreas in children worldwide. Interest in this condition has been fueled by the hypothesis that Streptococcus-induced antibodies targeted at basal ganglia neurons might account for tics and behavioral abnormalities among children (Cardoso 2002a). In the last two decades of the twentieth century, acquired immune deficiency syndrome (AIDS) was the infectious disease to receive the largest scientific and public attention. Soon after its discovery, movement disorders became recognized among the neurologic complications in patients with AIDS due to the HIV virus (Nath et al. 1987; Brew 2001). The introduction of highly active antiretroviral therapy has led to a remarkable decline in the frequency of occurrence of HIV-related neurologic disorders (Maschke et al. 2000; Cardoso 2002b). Table 6.1 summarizes the most common movement disorders associated with infectious agents.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Asbahr, F. R., Negrão, A. B., Gentil, V., Zanetta, D. M., da Paz, J. A., Marques-Dias, M. J., et al. (1998). “Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study,” Am. J. Psychiatry 155: 1122–4.CrossRefGoogle ScholarPubMed
Ayarza, A., Parisi, V., Altclas, J., Visconti, D., Persi, G., Rugilo, C. A., et al. (2009). “Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion,” J. Neurol. 256: 1024–5.CrossRefGoogle ScholarPubMed
Ayoub, E. M. (1992). “Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness,” Postgrad. Med. 92: 133–6.CrossRefGoogle ScholarPubMed
Baizabal-Carvallo, J. F. and Jankovic, J. (2012). “Movement disorders in autoimmune diseases,” Mov. Disord. 27: 935–46.CrossRefGoogle ScholarPubMed
Barash, J., Margalith, D., and Matitiau, A. (2005). “Corticosteroid treatment in patients with Sydenham’s chorea,” Pediatr. Neurol. 32: 205–7.CrossRefGoogle ScholarPubMed
Beato, R., Maia, D. P., Teixeira, A. L., and Cardoso, F. (2010). “Executive functioning in adult patients with Sydenham’s chorea,” Mov. Disord. 25: 853–7.CrossRefGoogle ScholarPubMed
Ben-Pazi, H., Sadan, O., and Offen, D. (2012). “Striatal microinjection of Sydenham chorea antibodies: using a rat model to examine the dopamine hypothesis,” J. Mol. Neurosci. 46: 162–6.CrossRefGoogle ScholarPubMed
Biesiada, G., Czapiel, J., Sobczyk-Krupiarz, I., Garlicki, A., and Mach, T. (2008). “Neuroborreliosis with extrapyramidal symptoms: a case report,” Pol. Arch. Med. Wewn. 118: 314–17.Google ScholarPubMed
Bouffard, J. P., Mena, H., Ripple, M., and Troncoso, J. (2003). “Mesencephalic cryptococcal abscesses presenting with parkinsonism as an initial manifestation of AIDS,” Mov. Disord. 18: 1354–7.CrossRefGoogle Scholar
Bremell, D., Säll, C., Gisslén, M., and Hagberg, L. (2011). “Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review,” J. Med. Case Rep. 19(5): 465, .CrossRefGoogle Scholar
Brew, B. J. (2001). HIV Neurology (New York: Oxford University Press).Google Scholar
Brilot, F., Merheb, V., Ding, A., Murphy, T., and Dale, R. C. (2011). “Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome,” Neurology 76: 1508–13.CrossRefGoogle ScholarPubMed
Brimberg, L., Benhar, I., Mascaro-Blanco, A., Alvarez, K., Lotan, D., Winter, C., et al. (2012). “Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders,” Neuropsychopharmacology 37: 2076–87.CrossRefGoogle ScholarPubMed
Bua, J., Marchetti, F., Barbi, E., Sarti, A., and Ventura, A. (2005). “Tremors and chorea induced by trimethoprim-sulfamethoxazole in a child with Pneumocystis pneumonia,” Pediatr. Infect. Dis. J. 24: 934–5.CrossRefGoogle Scholar
Canafoglia, L., Panzica, F., Franceschetti, S., Carriero, M. R., Ciano, C., Scaioli, V., et al. (2003). “Rhythmic cortical myoclonus in a case of HIV-related encephalopathy,” Mov. Disord. 18: 1533–8.CrossRefGoogle Scholar
Candler, P. M., Dale, R. C., Griffin, S., Church, A. J., Wait, R., Chapman, M. D., et al. (2006). “Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies,” J. Neurol. Neurosurg. Psychiatry 77(4): 507–12.CrossRefGoogle ScholarPubMed
Carapetis, J. R., Wolff, D. R., and Currie, B. J. (1996). “Acute rheumatic fever and rheumatic heart disease in the top end of Australia’s Northern Territory,” Med. J. Aust. 164: 146–9.Google ScholarPubMed
Cardesa-Salzmann, T. M., Mora, J., Garcia Cazorla, M. A., Cruz, O., Munoz, C., and Campistol, J. (2006). “Epstein-Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors,” Pediatr. Blood Cancer 47: 964–7.CrossRefGoogle Scholar
Cardoso, F. (2002a). “Infectious and transmissible movement disorders,” in Jankovic, J. and Tolosa, E. (eds.), Parkinson’s Disease and Movement Disorders, 4th edn. (Baltimore: Lippincott Williams & Wilkins), pp. 945–66.Google Scholar
Cardoso, F. (2002b). “HIV-related movement disorders: epidemiology, pathogenesis and management,” CNS Drugs 16: 663–8.CrossRefGoogle ScholarPubMed
Cardoso, F. (2004). “Chorea: non-genetic causes,” Curr. Opin. Neurol. 17: 433–6.CrossRefGoogle ScholarPubMed
Cardoso, F. (2005). “Tourette syndrome: autoimmune mechanism,” in Fernández-Álvarez, E., Arzimanoglou, A., and Tolosa, E. (eds.), Pediatric Movement Disorders. Progress in Understanding (Montrouge: John Libbey Eurotext), pp. 23–46.Google Scholar
Cardoso, F. (2008). “Sydenham’s chorea,” Curr. Treat. Options Neurol. 10: 230–5.CrossRefGoogle ScholarPubMed
Cardoso, F., Beato, R., Siqueira, C. F., and Lima, C. F. (2005a). “Neuropsychological performance and brain SPECT imaging in adult patients with Sydenham’s chorea,” Neurology 64(Suppl. 1): A76.Google Scholar
Cardoso, F., Dornas, L., Cunningham, M., and Oliveira, J. T. (2005b). “Nerve conduction study in Sydenham’s chorea,” Mov. Disord. 20: 360–3.CrossRefGoogle ScholarPubMed
Cardoso, F., Maia, D., Cunningham, M. C., and Valença, G. (2003). “Treatment of Sydenham chorea with corticosteroids,” Mov. Disord. 18: 1374–7.CrossRefGoogle ScholarPubMed
Cardoso, F., Seppi, K., Mair, K. J., Wenning, G. K., and Poewe, W. (2006). “Seminar on choreas,” Lancet Neurol. 5: 589–602.CrossRefGoogle ScholarPubMed
Cardoso, F., Silva, C. E., and Mota, C. C. (1997). “Sydenham’s chorea in 50 consecutive patients with rheumatic fever,” Mov. Disord. 12: 701–3.CrossRefGoogle ScholarPubMed
Cardoso, F., Vargas, A. P., Oliveira, L. D., Guerra, A. A., and Amaral, S. V. (1999). “Persistent Sydenham’s chorea,” Mov. Disord. 14: 805–7.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
Carrazana, E., Rossitch, E., and Samuels, M. A. (1989). “Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis,” J. Neurol. Neurosurg. Psychiatry 52: 1445–6.CrossRefGoogle Scholar
Chemli, J., Ketata, S., Dalhoumi, A., Ajmi, H., Hassayoun, S., Fodha, I., et al. (2007). “Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection,” Arch. Pediatr. (Paris) 14: 1003–6.CrossRefGoogle ScholarPubMed
Chen, Y. C., Lo, C. P., and Chang, T. P. (2010). “Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features – a case report,” J. Neurol. Sci. 298: 110–13.CrossRefGoogle ScholarPubMed
Church, A. J., Cardoso, F., Dale, R. C., Lee, A. J., Thompson, E. J., Giovannoni, G. (2002). “Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea,” Neurology 59: 227–31.CrossRefGoogle ScholarPubMed
Church, A. J., Dale, R. C., Cardoso, F., Candler, P. M., Chapman, M. D., Allen, M. L., et al. (2003a). “CSF and serum immune parameters in Sydenham’s chorea: evidence of an autoimmune syndrome?J. Neuroimmunol. 136: 149–53.CrossRefGoogle ScholarPubMed
Church, A. J., Dale, R. C., and Giovannoni, G. (2004). “Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?Arch. Dis. Child. 89: 611–14.CrossRefGoogle ScholarPubMed
Church, A. J., Dale, R. C., Lees, A. J., Giovannoni, G., and Robertson, M. M. (2003b). “Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis,” J. Neurol. Neurosurg. Psychiatry 74: 602–7.CrossRefGoogle ScholarPubMed
Clay, P. G. and Adams, M. M. (2003). “Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction,” Ann. Pharmacother. 37: 202–5.CrossRefGoogle ScholarPubMed
Crawford, J. R., Kadom, N., Santi, M. R., Mariani, B., and Lavenstein, B. L. (2007). “Human herpesvirus 6 rhombencephalitis in immunocompetent children,” J. Child Neurol. 22: 1260–8.CrossRefGoogle ScholarPubMed
Cunningham, M. C., Maia, D. P., Teixeira, A. L., and Cardoso, F. (2006). “Sydenham’s chorea is associated with decreased verbal fluency,” Parkinsonism Relat. Disord. 12: 165–7.CrossRefGoogle ScholarPubMed
Dale, R. C., Church, A. J., Benton, S., Surtees, R. A., Lees, A., Thompson, E. J., et al. (2002a). “Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis,” Dev. Med. Child Neurol. 44: 485–9.CrossRefGoogle ScholarPubMed
Dale, R. C., Church, A. J., Cardoso, F., Goddard, E., Cox, T. C., Chong, W. K., et al. (2001). “Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies,” Ann. Neurol. 50: 588–95.CrossRefGoogle ScholarPubMed
Dale, R. C., Church, A. J., Surtees, R. A., Thompson, E. J., Giovannoni, G., and Neville, B. G. (2002b). “Post-streptococcal autoimmune neuropsychiatric disease presenting as paroxysmal dystonic choreoathetosis,” Mov. Disord. 17: 817–20.CrossRefGoogle ScholarPubMed
Dale, R. C., Church, A. J., Surtees, R. A., Lees, A. J., Adcock, J. E., Harding, B., et al. (2004b). “Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity,” Brain 127: 21–33.CrossRefGoogle ScholarPubMed
Dale, R. C., Heyman, I., Surtees, R. A., Church, A. J., Giovannoni, G., Goodman, R., et al. (2004a). “Dyskinesias and associated psychiatric disorders following streptococcal infections,” Arch. Dis. Child. 89: 604–10.CrossRefGoogle ScholarPubMed
Dale, R. C., Yin, K., Ding, A., Merheb, V., Varadkhar, S., McKay, D., et al. (2011). “Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies,” Dev. Med. Child Neurol. 53(6): 522–8.CrossRefGoogle ScholarPubMed
de la Fuente-Aguado, J., Bordón, J., Moreno, J. A., Sopeña, B., Rodriguez, A., and Martínez-Vázquez, C. (1996). “Parkinsonism in an HIV-infected patient with hypodense cerebral lesion,” Tuber. Lung Dis. 77(2): 191–2.CrossRefGoogle Scholar
Doyle, F., Cardoso, F., Lopes, L., Mendes, M., Dias, F., Cruz, L., et al. (2012). “Infusion of Sydenham’s chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity,” Neurosci. Lett. 523(2): 186–9.CrossRefGoogle ScholarPubMed
Edwards, M. J., Dale, R. C., Church, A. J., Trikouli, E., Quinn, N. P., Lees, A. J., et al. (2004). “Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies,” Mov. Disord. 19: 1190–6.CrossRefGoogle ScholarPubMed
Espay, A. J. and Henderson, K. K. (2011). “Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection,” Neurology 76: 1529–30.CrossRefGoogle ScholarPubMed
Factor, S. A., Troche-Panetto, M., and Weaver, S. A. (2003). “Dystonia in AIDS: report of four cases,” Mov. Disord. 18: 1492–8.CrossRefGoogle ScholarPubMed
Feldman, B. M., Zabriskie, J. B., Silverman, E. D., and Laxer, R. M. (1993). “Diagnostic use of B-cell alloantigen D8/17 in rheumatic chorea,” J. Pediatr. 123: 84–6.CrossRefGoogle ScholarPubMed
Flabeau, O., Meissner, W., Foubert-Samier, A., Guehl, D., Desbordes, P., and Tison, F. (2009). “Opsoclonus myoclonus syndrome in the context of Salmonellosis,” Mov. Disord. 24: 2306–8.CrossRefGoogle ScholarPubMed
Gabbay, V., Coffey, B. J., Babb, J. S., Meyer, L., Wachtel, C., Anam, S., et al. (2008). “Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic,” Pediatrics 122: 273–8.CrossRefGoogle Scholar
Gaig, C., Muñoz, E., Valls-Solé, J., Martí, M. J., and Tolosa, E. (2007). “Eating-induced facial myoclonic dystonia probably due to a putaminal lesion,” Mov. Disord. 22: 877–80.CrossRefGoogle ScholarPubMed
Garvey, M. A., Perlmutter, S. J., Allen, A. J., Hamburger, S., Lougee, L., Leonard, H. L., et al. (1999). “A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections,” Biol. Psychiatry 45: 1564–71.CrossRefGoogle ScholarPubMed
González-Duarte, A., Magaña Zamora, L., Cantú Brito, C., and García-Ramos, G. (2010). “Hypothalamic abnormalities and Parkinsonism associated with H1N1 influenza infection,” J. Neuroinflammation 7: 47.CrossRefGoogle ScholarPubMed
Greinacher, A., Friesecke, S., Abel, P., Dressel, A., Stracke, S., Fiene, M., et al. (2011). “Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial,” Lancet Neurol. 378: 1166–73.CrossRefGoogle ScholarPubMed
Guan, J., Lu, Z., and Zhou, Q. (2012). “Reversible parkinsonism due to involvement of substantia nigra in Epstein-Barr virus encephalitis,” Mov. Disord. 27: 156–7.CrossRefGoogle ScholarPubMed
Hersh, B. P., Rajendran, P. R., and Battinelli, D. (2001). “Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART,” Neurology 56: 278–9.CrossRefGoogle ScholarPubMed
Hounie, A. G., Pauls, D. L., Mercadante, M. T., Rosário-Campos, M. C., Shavitt, R. G., de Mathis, M. A., et al. (2004). “Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydenham’s chorea,” J. Clin. Psychiatry 65: 994–9.CrossRefGoogle ScholarPubMed
Huber, B. M., Strozzi, S., Steinlin, M., Aebi, C., and Fluri, S. (2010). “Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases,” Eur. J. Pediatr. 169: 441–5.CrossRefGoogle ScholarPubMed
Husby, G., van de Rijn, I., Zabriskie, J. B., Abdin, Z. H., and Williams, R. C., (1976). “Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever,” J. Exp. Med. 144: 1094–110.CrossRefGoogle ScholarPubMed
Imai, N., Yagi, N., Konishi, T., Serizawa, M., and Kobari, M. (2008). “Legionnaires’ disease with hypoperfusion in the cerebellum and frontal lobe on single photon emission computed tomography,” Intern. Med. 47: 1263–6.CrossRefGoogle ScholarPubMed
Jang, W., Kim, J. S., Ahn, J. Y., and Kim, H. T. (2012). “Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection,” Neurol. Sci. 33(5): 1169–71.CrossRefGoogle ScholarPubMed
Jankovic, J. (1986). “Whipple’s disease of the central nervous system in AIDS,” N. Engl. J. Med. 315: 1029–30.Google Scholar
Jankovic, J. and Clarence-Smith, K. (2011). “Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders,” Expert Review of Neurotherapeutics 11: 1509–23.CrossRefGoogle ScholarPubMed
Kanjanasut, N., Phanthumchinda, K., and Bhidayasiri, R. (2010). “HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases,” Clin. Neurol. Neurosurg. 112: 572–4.CrossRefGoogle ScholarPubMed
Kansy, J. W., Katsovich, L., McIver, K. S., Pick, J., Zabriskie, J. B., Lombroso, P. J., et al. (2006). “Identification of pyruvate kinase as an antigen associated with Tourette syndrome,” J. Neuroimmunol. 181: 165–76.CrossRefGoogle ScholarPubMed
Kieburtz, K. D., Epstein, L. G., Gelbard, H. A., and Greenamyre, J. T. (1991). “Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications,” Arch. Neurol. 48: 1281–4.CrossRefGoogle ScholarPubMed
Kim, J. S., Choi, I. S., and Lee, M. C. (1995). “Reversible parkinsonism and dystonia following probable Mycoplasma pneumoniae infection,” Mov. Disord. 10: 510–12.CrossRefGoogle ScholarPubMed
Kirvan, C. A., Cox, C. J., Swedo, S. E., and Cunningham, M. W. (2007). “Tubulin is a neuronal target of autoantibodies in Sydenham’s chorea,” J. Immunol. 178:7412–21.CrossRefGoogle ScholarPubMed
Kirvan, C. A., Swedo, S. E., Heuser, J. S., and Cunningham, M. W. (2003). “Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea,” Nat. Med. 9: 914–20.CrossRefGoogle ScholarPubMed
Kirvan, C. A., Swedo, S. E., Kurahara, D., and Cunningham, M. W. (2006). “Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea,” Autoimmunity 39: 21–9.CrossRefGoogle ScholarPubMed
Koppel, B. S. and Daras, M. (1990). “‘Rubral’ tremor due to midbrain Toxoplasma abscess,” Mov. Disord. 5: 254–6.CrossRefGoogle ScholarPubMed
Kummer, A., Maia, D. P., Cardoso, F., and Teixeira, A. L. (2007). “Trichotillomania in acute Sydenham’s chorea,” Aust. NZ J. Psychiatry 41: 1013–14.Google ScholarPubMed
Kurlan, R. (2004). “The PANDAS hypothesis: losing its bite?Mov. Disord. 19: 371–4.CrossRefGoogle ScholarPubMed
Kurlan, R., Johnson, D., and Kaplan, E. L. (2008). “Tourette Syndrome Study Group. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study,” Pediatrics 121: 1188–97.CrossRefGoogle Scholar
Kwak, C., Dat Vuong, K., and Jankovic, J. (2003a). “Premonitory sensory phenomenon in Tourette’s syndrome,” Mov. Disord. 18: 1530–3.CrossRefGoogle ScholarPubMed
Kwak, C., Vuong, K. D., and Jankovic, J. (2003b). “Migraine headache in patients with Tourette Syndrome,” Arch. Neurol. 60: 1595–8.CrossRefGoogle ScholarPubMed
Lannuzel, A., Hermann, C., Yousry, C., Lees, A., and Caparros-Lefebvre, D. (2002). “Encephalomyelitis with rigidity complicating human immunodeficiency virus infection,” Mov. Disord. 17: 202–4.CrossRefGoogle ScholarPubMed
Leger, G. C., Johnson, N., Horowitz, S. W., Dale, R. C., Church, A. J., and Mesulam, M. M. (2004). “Dementia-like presentation of striatal hypermetabolic state with antistriatal antibodies responsive to steroids,” Arch. Neurol. 61: 754–7.CrossRefGoogle ScholarPubMed
Lera, G. and Zirulnik, J. (1999). “Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism,” Mov. Disord. 14: 128–31.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
Lin, H., Williams, K. A., Katsovich, L., Findley, D. B., Grantz, H., Lombroso, P. J., et al. (2010). “Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder,” Biol. Psychiatry 67: 684–91.CrossRefGoogle ScholarPubMed
Loiselle, C. R., Lee, O., Moran, T. H., and Singer, H. S. (2004). “Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes,” Mov. Disord. 19: 390–6.CrossRefGoogle ScholarPubMed
Loiselle, C. R., Wendlandt, J. T., Rohde, C. A., and Singer, H. S. (2003). “Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome,” Pediatr. Neurol. 28:119–25.CrossRefGoogle ScholarPubMed
Lopez, O. L., Smith, G., Meltzer, C. C., and Becker, J. T. (1999). “Dopamine systems in human immunodeficiency virus-associated dementia,” Neuropsychiatry Neuropsychol. Behav. Neurol. 12: 184–92.Google ScholarPubMed
Maia, D. P., Fonseca, P. G., Camargos, S. T., Pfannes, C., Cunningham, M. C., and Cardoso, F. (2012). “Pregnancy in patients with Sydenham’s chorea,” Parkinsonism Relat. Disord. 18: 458–61.CrossRefGoogle ScholarPubMed
Maia, D. P., Teixeira, A. L., Quintao Cunningham, M. C., and Cardoso, F. (2005). “Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea,” Neurology 64: 1799–801.CrossRefGoogle ScholarPubMed
Manji, H., Sweeney, B., and Connolly, S. (1995). “Movement disorders in AIDS: infective, neoplastic and iatrogenic causes,” Parkinsonism Relat. Disord. 1: 13–19.CrossRefGoogle ScholarPubMed
Martino, D., Chiarotti, F., Buttiglione, M., Cardona, F., Creti, R., Nardocci, N., et al. (2011). “Italian Tourette Syndrome Study Group. The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort,” Dev. Med. Child Neurol. 53: 951–7.CrossRefGoogle Scholar
Maschke, M., Kastrup, O., Esser, S., Ross, B., Henge, U., and Hufnagel, A. (2000). “Incidence and prevalence of neurological disorders associated with HIV infection since the introduction of highly active antiretroviral therapy (HAART),” J. Neurol. Neurosurg. Psychiatry 69: 376–80.CrossRefGoogle Scholar
Matsuo, M., Tsuchiya, K., Hamasaki, Y., and Singer, H. S. (2004). “Restless legs syndrome: association with streptococcal or mycoplasma infection,” Pediatr. Neurol. 31: 119–21.CrossRefGoogle ScholarPubMed
McDaniel, J. S. and Summerville, M. B. (1994). “Tic disorder associated with encephalopathy in advanced HIV disease,” Gen. Hosp. Psychiatry 16: 298–300.CrossRefGoogle ScholarPubMed
McKee, D. H. and Sussman, J. D. (2005). “Case report: severe acute Parkinsonism associated with streptococcal infection and antibasal ganglia antibodies,” Mov. Disord. 20: 1661–3.CrossRefGoogle ScholarPubMed
Medrano, V., Royo-Villanova, C., Flores-Ruiz, J. J., Sempere, A. P., and Mola-Caballero de Roda, S. (2005). “Parainfectious opsoclonus-myoclonus syndrome secondary to varicella-zoster virus infection,” Rev. Neurol. 41: 507–8.Google ScholarPubMed
Mercadante, M. T., Busatto, G. F., Lombroso, P. J., Prado, L., Rosário-Campos, M. C., do Valle, R., et al. (2000). “The psychiatric symptoms of rheumatic fever,” Am. J. Psychiatr. 157: 2036–8.CrossRefGoogle ScholarPubMed
Micheli, F., Granana, N., Scorticati, M. C., Giannaula, R. J., and Reboredo, G. (1997). “Unilateral postural and action tremor resulting from thalamic toxoplasmosis in a patient with acquired immunodeficiency syndrome,” Mov. Disord. 12: 1096–8.CrossRefGoogle Scholar
Miranda, M., Cardoso, F., Giovannoni, G., and Church, A. (2004). “Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies,” J. Neurol. Neurosurg. Psychiatry. 75: 327–8.Google ScholarPubMed
Mirsattari, S. M., Berry, M. E., Holden, J. K., Ni, W., Nath, A., and Power, C. (1999). “Paroxysmal dyskinesias in patients with HIV infection,” Neurology 52: 109–14.CrossRefGoogle ScholarPubMed
Mirsattari, S. M., Power, C., and Nath, A. (1998). “Parkinsonism with HIV infection,” Mov. Disord. 13: 684–9.CrossRefGoogle ScholarPubMed
Misra, U. K., Kalita, J., Syam, U. K., and Dhole, T. N. (2006). “Neurological manifestations of dengue virus infection,” J. Neurol. Sci. 244: 117–22.CrossRefGoogle ScholarPubMed
Muller, N., Riedel, M., Blendinger, C., Oberle, K., and Jacobs Abele-Horn, M. (2004). “Mycoplasma pneumoniae infection and Tourette’s syndrome,” Psychiatry Res. 129: 119–25.CrossRefGoogle ScholarPubMed
Nath, A., Jankovic, J., and Pettigrew, L. C. (1987). “Movement disorders and AIDS,” Neurology 37: 37–41.CrossRefGoogle ScholarPubMed
Nausieda, P. A., Grossman, B. J., Koller, W. C., Weiner, W. J., and Klawans, H. L.(1980). “Sydenham chorea: an update,” Neurology 30: 331–4.CrossRefGoogle ScholarPubMed
Nunes, J. C., Bruscato, A. M., Walz, R., and Lin, K. (2011). “Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection in an elderly patient,” J. Neurol. Sci. 305: 147–8.CrossRefGoogle Scholar
Pardo, J., Marcos, A., Bhathal, H., Castro, M., and Varea de Seijas, E. (1998). “Chorea as a form of presentation of human immunodeficiency virus-associated dementia complex,” Neurology 50: 568–9.CrossRefGoogle ScholarPubMed
Passarin, M. G., Alessandrini, F., Nicolini, G. G., Musso, A., Gambina, G., and Moretto, G. (2005). “Reversible choreoathetosis as the early onset of HIV-encephalopathy,” Neurol. Sci. 26: 55–6.CrossRefGoogle ScholarPubMed
Peter, L., Jung, J., Tilikete, C., Ryvlin, P., and Mauguiere, F. (2006). “Opsoclonus-myoclonus as a manifestation of Lyme disease,” J. Neurol. Neurosurg. Psychiatry 77: 1090–1.CrossRefGoogle ScholarPubMed
Piccolo, I., Causarano, R., Sterzi, R., Sberna, M., Oreste, P. L., Moioli, C., et al. (1999). “Chorea in patients with AIDS,” Acta Neurol. Scand. 100: 332–6.CrossRefGoogle ScholarPubMed
Ramasawmy, R., Faé, K. C., Spina, G., Victora, G. D., Tanaka, A. C., Palácios, S. A., et al. (2007). “Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever,” Mol. Immunol. 44: 1873–8.CrossRefGoogle ScholarPubMed
Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., et al. (2011). “Helicobacter pylori eradication for Parkinson’s disease,” Cochrane Database Syst. Rev. 9(11): CD008453.Google Scholar
Rieder, C. R. and Ziomkowski, S. C. (2005). “Head tremor and progressive multifocal leukoencephalopathy in AIDS patients: report of two cases,” Arq. Neuropsiquiatr. 63: 150–3.CrossRefGoogle ScholarPubMed
Sacktor, N. C., Skolasky, R. L., Lyles, R. H., Esposito, D., Selnes, O. A., and McArthur, J. C. (2000). “Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors,” J. Neurovirol. 6: 84–8.CrossRefGoogle ScholarPubMed
Sardar, A. M., Czudek, C., and Reynolds, G. P. (1996). “Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS,” Neuroreport 7: 910–12.CrossRefGoogle Scholar
Schrag, A., Gilbert, R., Giovannoni, G., Robertson, M. M., Metcalfe, C., and Ben-Shlomo, Y. (2009). “Streptococcal infection, Tourette syndrome, and OCD: is there a connection?” Neurology 73: 1256–63.CrossRefGoogle Scholar
Schwartz, R. H., Hepner, S. I., and Ziai, M. (1983). “Incidence of acute rheumatic fever. A suburban community hospital experience during the 1970s,” Clin. Pediatr. 22: 798–801.CrossRefGoogle ScholarPubMed
Senbil, N., Yapici, Z., and Gürer, Y. K. (2008). “Paroxysmal non-kinesigenic and hypnogenic dyskinesia associated with Streptococcal infection,” Pediatr. Int. 50: 255–6.CrossRefGoogle ScholarPubMed
Sevigny, J. J., Chin, S. S., Milewski, Y., Albers, M. W., Gordon, M. L., and Marder, K. (2005). “HIV encephalitis simulating Huntington’s disease,” Mov. Disord. 20: 610–13.CrossRefGoogle ScholarPubMed
Shah, B. B. and Lang, A. E. (2012). “Acquired neurosyphilis presenting as movement disorders,” Mov. Disord. 27: 690–5.CrossRefGoogle ScholarPubMed
Shah, I. and Chudgar, P. (2005). “Progressive multifocal leukoencephalopathy (PML) presenting as intractable dystonia in an HIV-infected child,” J. Trop. Pediatr. 51: 380–2.CrossRefGoogle Scholar
Singer, C., Sanchez-Ramos, J., Rey, G., Levin, B., and Weiner, W. J. (1990). “AIDS dementia complex presenting as an unusual unilateral hand tremor, clumsiness and posturing,” Ann. Neurol. 28: 301.Google Scholar
Singer, H. S., Gause, C., Morris, C., and Lopez, P. (2008). “Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections,” Pediatrics 121: 1198–205.CrossRefGoogle Scholar
Singer, H. S., Gilbert, D. L., Wolf, D. S., Mink, J. W., and Kurlan, R. (2012). “Moving from PANDAS to CANS,” J. Pediatr. 160: 725–31.CrossRefGoogle ScholarPubMed
Singer, H. S., Giuliano, J. D., Hansen, B. H., Hallett, J. J., Laurino, J. P., Benson, M., et al. (1998). “Antibodies against human putamen in children with Tourette syndrome,” Neurology 50: 1618–24.CrossRefGoogle ScholarPubMed
Singer, H. S., Loiselle, C. R., Lee, O., Garvey, M. A., and Grus, F. H. (2003). “Anti-basal ganglia antibody abnormalities in Sydenham chorea,” J. Neuroimmunol. 136: 154–61.CrossRefGoogle ScholarPubMed
Singer, H. S., Loiselle, C. R., Lee, O., Minzer, K., Swedo, S., and Grus, F. H. (2004). “Anti-basal ganglia antibodies in PANDAS,” Mov. Disord. 19: 406–15.CrossRefGoogle ScholarPubMed
Singh, D., Sinha, M., Kumar, R., Shukla, R., and Ahuja, R. C. (2010). “Opsoclonus-myoclonus syndrome caused by varicella-zoster virus,” Ann. Indian Acad. Neurol. 13: 211–12.Google ScholarPubMed
Skeie, G. O., Eldoen, G., Skeie, B. S., Midgard, R., Kristoffersen, E. K., Bindoff, L. A. (2007). “Opsoclonus myoclonus syndrome in two cases with neuroborreliosis,” Eur. J. Neurol. 14: e1–2.CrossRefGoogle ScholarPubMed
Snider, L. A., Lougee, L., Slattery, M., Grant, P., and Swedo, S. E. (2005). “Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders,” Biol. Psychiatry 57: 788–92.CrossRefGoogle ScholarPubMed
Snider, L. A., Sachdev, V., MaCkaronis, J. E., Peter, M., and Swedo, S. E., (2004). “Echocardiographic findings in the PANDAS subgroup,” Pediatrics 114: e748–51.CrossRefGoogle ScholarPubMed
Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association (1992). “Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update,” JAMA 268: 2069–73.CrossRefGoogle Scholar
Sporer, B., Seelos, K., Asmus, F., Boetzel, K., and Pfister, H. W. (2005). “Posterior fossa tremor induced by HIV-associated progressive multifocal leukoencephalopathy,” Eur. Neurol. 53: 96–7.CrossRefGoogle ScholarPubMed
Squintani, G., Tinazzi, M., Gambarin, M., Bravi, E., Moretto, G., Buttiglione, M., Defazio, G., and Martino, D. (2010). “Post-streptococcal ‘complex’ movement disorders: unusual concurrence of psychogenic and organic symptoms,” J. Neurol. Sci. 288: 68–71.CrossRefGoogle ScholarPubMed
Swedo, S. E. (1994). “Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders [clinical conference],” JAMA 272: 1788–91.CrossRefGoogle Scholar
Swedo, S. E., Leckman, J. F., and Rose, N. R. (2012). “From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome),” Pediatr. Therapeut. 2: 2–8.CrossRefGoogle Scholar
Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., et al. (1988). “Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases,” Am. J. Psychiatry 155: 264–71.Google Scholar
Swenson, J. R., Erman, M., Labelle, J., and Dimsdale, J. E. (1989). “Extrapyramidal reactions. Neuropsychiatric mimics in patients with AIDS,” Gen. Hosp. Psychiatry 11: 248–53.CrossRefGoogle ScholarPubMed
Taranta, A. and Stollerman, G. H. (1956). “The relationship of Sydenham’s chorea to infection with group A streptococci,” Am. J. Med. 20: 170–5.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Cardoso, F., Maia, D. P., and Cunningham, M. C. (2003). “Sydenham’s chorea may be a risk factor for drug induced parkinsonism,” J. Neurol. Neurosurg. Psychiatry 74: 1350–1.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Cardoso, F., Maia, D. P., Sacramento, D. R., Mota Cde, C., Meira, Z. M., et al. (2009). “Frequency and significance of vocalizations in Sydenham’s chorea,” Parkinsonism Relat. Disord. 15: 62–3.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Cardoso, F., Souza, A. L., and Teixeira, M. M. (2004). “Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham’s chorea patients,” J. Neuroimmunol. 150: 157–62.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Guimaraes, M. M., Romano-Silva, M. A., and Cardoso, F. (2005a). “Serum from Sydenham’s chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism,” Mov. Disord. 20: 843–5.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Maia, D. P., and Cardoso, F. (2005b). “UFMG Sydenham’s chorea rating scale (USCRS): reliability and consistency,” Mov. Disord. 20: 585–91.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Maia, D. P., and Cardoso, F. (2005c). “Treatment of acute Sydenham’s chorea with methyl-prednisolone pulse-therapy,” Parkinsonism Relat. Disord. 11: 327–30.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Maia, D. P., and Cardoso, F. (2007). “Psychosis following acute Sydenham’s chorea,” Eur. Child Adolesc. Psychiatry 16: 67–9.CrossRefGoogle ScholarPubMed
Teixeira, A. L., Meira, F. C., Maia, D. P., Cunningham, M. C., and Cardoso, F. (2005d). “Migraine headache in patients with Sydenham’s chorea,” Cephalalgia 25: 542–4.CrossRefGoogle ScholarPubMed
Tolge, C. F. and Factor, S. A. (1991). “Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome,” Mov. Disord. 6: 69–72.CrossRefGoogle Scholar
Torres, K. C., Dutra, W. O., de Rezende, V. B., Cardoso, F., Gollob, K. J., and Teixeira, A. L. (2010). “Monocyte dysfunction in Sydenham’s chorea patients,” Hum. Immunol. 71: 351–4.CrossRefGoogle ScholarPubMed
Trocello, J. M., Blanchet, A., Bourdain, F., Meyohas, M. C., and Vidailhet, M. (2006). “Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy,” Rev. Neurol. (Paris) 162: 89–91.CrossRefGoogle ScholarPubMed
Vale, T. C., Maciel, R. O., Maia, D., Beato, R., and Cardoso, F. (2012). “Takayasu’s arteritis in a patient with Sydenham’s chorea: is there an association?Tremor & Other Hyperkinet Mov. 2, .Google Scholar
van Toorn, R., Rabie, H., and Warwick, J. M. (2005). “Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy – possible immune reconstitution inflammatory syndrome,” Eur. J. Paediatr. Neurol. 9: 423–6.CrossRefGoogle Scholar
Verma, R., Sharma, P., Garg, R. K., Atam, V., Singh, M. K., and Mehrotra, H. S. (2011). “Neurological complications of dengue fever: experience from a tertiary center of north India,” Ann. Indian Acad. Neurol. 14: 272–8.CrossRefGoogle ScholarPubMed
Weisz, J. L., McMahon, W. M., Moore, J. C., Augustine, N. H., Bohnsack, J. F., Bale, J. F., et al. (2004). “D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette’s disorder,” Clin. Diagn. Lab. Immunol. 11: 330–6.Google ScholarPubMed
Wicki, J., Germanier, Y., Sztajzel, R., and Burkhard, P. R. (2008). “Brueghel syndrome as a new manifestation of HIV encephalopathy,” Eur. Neurol. 60: 107–8.CrossRefGoogle ScholarPubMed
Wiersinga, W. J., Prins, J. M., and van de Beek, D. (2012). “Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection,” Clin. Infect. Dis. 54: 447–8.CrossRefGoogle ScholarPubMed
Wong, A. (2007). “An update on opsoclonus,” Curr. Opin. Neurol. 20: 25–31.CrossRefGoogle ScholarPubMed
Zaganas, I., Prinianakis, G., Xirouchaki, N., and Mavridis, M. (2007). “Opsoclonus-myoclonus syndrome associated with cytomegalovirus encephalitis,” Neurology 68: 1636.CrossRefGoogle ScholarPubMed
Zomorrodi, A. and Wald, E. R. (2006). “Sydenham’s chorea in western Pennsylvania,” Pediatrics 117: e675–9.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Movement disorders in systemic infections
    • By Francisco Cardoso, Movement Disorders Unit, Neurology Division, Internal Medicine Department, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Book: Movement Disorders in Neurologic and Systemic Disease
  • Online publication: 05 April 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139175845.007
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Movement disorders in systemic infections
    • By Francisco Cardoso, Movement Disorders Unit, Neurology Division, Internal Medicine Department, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Book: Movement Disorders in Neurologic and Systemic Disease
  • Online publication: 05 April 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139175845.007
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Movement disorders in systemic infections
    • By Francisco Cardoso, Movement Disorders Unit, Neurology Division, Internal Medicine Department, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Book: Movement Disorders in Neurologic and Systemic Disease
  • Online publication: 05 April 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139175845.007
Available formats
×